CHRS SG&A Expenses
Coherus Oncology Inc · SG&A Expenses
CHRS SG&A Expenses
Latest reported$90.50Mperiod ending
CHRS SG&A Expenses ($5.53M → $90.50M)
Annual SG&A Expenses
High-resolution chart · PNG
CHRS sg&a expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 99,004,000 | |
| 150,438,000 | |
| 185,615,000 | |
| 198,481,000 | |
| 169,713,000 | |
| 139,079,000 | |
| 137,037,000 | |
| 94,177,000 | |
| 71,303,000 | |
| 51,597,000 | |
| 36,046,000 | |
| 17,564,000 | |
| 7,465,000 | |
| 5,531,000 |